Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
Share Market News
Here's why Medical Developments (ASX: MVP) share price has soared 12% today
⏸️ Investing
Will the Medical Developments share price recover?
Share Fallers
Medical Developments International share price tumbles on FY 2020 profit decline
Share Gainers
Why the Medical Developments International share price jumped 14% higher today
Healthcare Shares
3 junior ASX healthcare shares with explosive growth potential
⏸️ Investing
Why Opthea shares could offer big growth potential
⏸️ Investing
Why this underperforming ASX healthcare company could still light up the market in 2020 and beyond
⏸️ Investing
Why the Nearmap share price and one other are on my buy list
⏸️ Investing
2 ASX shares to buy with $5000 today
How to invest
Are you ready for another ASX correction in 2020?
Share Market News
3 ASX healthcare shares with overseas income exposure
Share Gainers
3 ASX shares that are up over 100% in the last month
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
